(Q38544959)

4 September 2017

1 reference

title

The Vero cell-derived, inactivated, SA14-14-2 strain-based vaccine (Ixiaro) for prevention of Japanese encephalitis (English)

1 reference

Japanese encephalitis virus

4 September 2017

0 references

author name string

Elina O Erra

series ordinal

1

1 reference

PubMed ID

26162529

4 September 2017

Anu Kantele

series ordinal

2

1 reference

4 September 2017

10 July 2015

1 reference

Expert Review of Vaccines

4 September 2017

1 reference

4 September 2017

14

1 reference

4 September 2017

9

1 reference

4 September 2017

1167-1179

1 reference

Estimated global incidence of Japanese encephalitis: a systematic review

4 September 2017

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1061939

Origin and Evolution of Japanese Encephalitis Virus in Southeast Asia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1061939

Phylogenetic analysis suggests only one serotype of Japanese encephalitis virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1061939

Ecology and geographical expansion of Japanese encephalitis virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1061939

Shift in Japanese encephalitis virus (JEV) genotype circulating in northern Vietnam: implications for frequent introductions of JEV from Southeast Asia to East Asia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1061939

Change in Japanese Encephalitis Virus Distribution,Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1061939

Molecular epidemiology of Japanese encephalitis virus circulating in South Korea, 1983-2005

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1061939

Dynamics of the emergence and establishment of a newly dominant genotype of Japanese encephalitis virus throughout Asia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1061939

Molecular epidemiology of Japanese encephalitis virus in mosquitoes in Taiwan during 2005-2012.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1061939

Genotype v Japanese encephalitis virus is emerging

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1061939

Emergence of Japanese encephalitis virus genotype V in the Republic of Korea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1061939

Detection of Japanese encephalitis virus genotype V in Culex orientalis and Culex pipiens (Diptera: Culicidae) in Korea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1061939

Japanese encephalitis virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1061939

Evidence and rationale for the World Health Organization recommended standards for Japanese encephalitis surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1061939

Japanese encephalitis in a Finnish traveler on a two-week holiday in Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1061939

Japanese encephalitis in travelers: review of cases and seasonal risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1061939

Japanese encephalitis: defining risk incidence for travelers to endemic countries and vaccine prescribing from the UK and Switzerland

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1061939

Japanese encephalitis in travelers from non-endemic countries, 1973-2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1061939

Japanese encephalitis in a Danish short-term traveler to Cambodia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1061939

Epidemiology of Japanese encephalitis in South Korea, 2007-2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1061939

Two laboratory-confirmed cases of Japanese encephalitis imported to Germany by travelers returning from Southeast Asia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1061939

Japanese encephalitis in a French traveler to Nepal

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1061939

A case series of three US adults with Japanese encephalitis, 2010-2012

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1061939

A case of Japanese encephalitis virus infection acquired during a trip in Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1061939

IMOJEV(®): a Yellow fever virus-based novel Japanese encephalitis vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1061939

Japanese encephalitis virus live-attenuated vaccine, Chinese strain SA14-14-2; adaptation to primary canine kidney cell cultures and preparation of a vaccine for human use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1061939

A purified inactivated Japanese encephalitis virus vaccine made in Vero cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1061939

Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO(®)) induced neutralizing antibody titers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1061939

A Phase 2 study of a purified, inactivated virus vaccine to prevent Japanese encephalitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1061939

Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1061939

Comparison of a single, high-dose vaccination regimen to the standard regimen for the investigational Japanese encephalitis vaccine, IC51: a randomized, observer-blind, controlled Phase 3 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1061939

Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese Encephalitis vaccine IC51 and the hepatitis A vaccine HAVRIX1440 in healthy subjects: A single-blind, randomized, controlled Phase 3 study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1061939

Immunogenicity of one dose of Vero cell culture-derived Japanese encephalitis (JE) vaccine in adults previously vaccinated with mouse brain-derived JE vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1061939

A single dose of vero cell-derived Japanese encephalitis (JE) vaccine (Ixiaro) effectively boosts immunity in travelers primed with mouse brain-derived JE vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1061939

Cross-protective capacity of Japanese encephalitis (JE) vaccines against circulating heterologous JE virus genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1061939

Co-administration of a meningococcal glycoconjugate ACWY vaccine with travel vaccines: a randomized, open-label, multi-center study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1061939

Long-term immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis virus vaccine IC51 Six and 12 month results of a multicenter follow-up phase 3 study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1061939

Cross-protection elicited by primary and booster vaccinations against Japanese encephalitis: a two-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1061939

Primary and booster immune responses to SA14-14-2 Japanese encephalitis vaccine in Korean infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1061939

Immunogenicity of single-dose Vero cell-derived Japanese encephalitis vaccine in Japanese adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1061939

Effect of pre-existing anti-tick-borne encephalitis virus immunity on neutralising antibody response to the Vero cell-derived, inactivated Japanese encephalitis virus vaccine candidate IC51.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1061939

Vaccination in the elderly: an immunological perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1061939

Immunogenicity and safety of IXIARO (IC51) in a Phase II study in healthy Indian children between 1 and 3 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1061939

Safety profile of the Vero cell-derived Japanese encephalitis virus (JEV) vaccine IXIARO(®).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1061939

Adverse events following vaccination with an inactivated, Vero cell culture-derived Japanese encephalitis vaccine in the United States, 2009-2012.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1061939

Safety analysis of a Vero-cell culture derived Japanese encephalitis vaccine, IXIARO (IC51), in 6 months of follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1061939

Long-term immunity and immune response to a booster dose following vaccination with the inactivated Japanese encephalitis vaccine IXIARO®, IC51

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1061939

Long term immunity following a booster dose of the inactivated Japanese Encephalitis vaccine IXIARO®, IC51

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1061939

10.1586/14760584.2015.1061939

21 January 2018

Identifiers

DOI

1 reference

release_sq7or4ypejcyncyzdhoopjkfci

4 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/sq7or4ypejcyncyzdhoopjkfci

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

26162529

1 reference

PubMed ID

26162529